Photoaffinity labeling combined with mass spectrometric approaches as a tool for structural proteomics

Expert Review of Proteomics

Volumn 3, Issue 4, 2006, Pages 399-408

  Robinette, David ^a   Neamati, Nouri ^b   Tomer, Kenneth B ^c   Borchers, Christoph H ^a  

^a DUKE UNIVERSITY   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Mass spectrometry; Molecular modeling; Photoaffinity labeling; Photolabeling; Protein drug interactions; Protein peptide interactions; Stoichiometry; Structural proteomics; Structure based drug design

Indexed keywords

BENZOPHENONE; LIGAND; OLIGONUCLEOTIDE;

DRUG PROTEIN BINDING; MASS SPECTROMETRY; PHOTOAFFINITY LABELING; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN CROSS LINKING; PROTEIN DNA INTERACTION; PROTEIN PROTEIN INTERACTION; PROTEIN QUATERNARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; REVIEW; STRUCTURAL PROTEOMICS;

AZIDES; BENZOPHENONES; DIAZOMETHANE; LIGANDS; MASS SPECTROMETRY; MODELS, MOLECULAR; PHOTOAFFINITY LABELS; PROTEIN INTERACTION MAPPING; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; ULTRAVIOLET RAYS;

EID: 33747190864     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/14789450.3.4.399     Document Type: Review

References (46)

1. Sing A, Thornton ER, Westheimer FH. The photolysis of diazoacetylchymotrypsin. J. Biol. Chem. 237(9), PC3006-PC3008 (1962). • Earliest report of the use of photoaffinity chemistry in biochemistry.
2. Fleming SA. Chemical reagents in photoaffinity labeling. Tetrahedron 51(46), 12479-12520 (1995).
3. Brunner J. New photolabeling and crosslinking methods. Ann. Rev. Biochem. 62, 483-514 (1993).
4. Dormán G, Prestwich GD. Using photolabile ligands in drug discovery and development. Trends Biotechnol. 18, 64-77 (2000). •• Focuses on how photoaffinity labeling techniques are used in drug discovery, but does not delve deeply into mass spectrometry.
5. Weber PJ, Beck-Sickinger AG. Comparison of the photochemical behavior of four different photo-activatable probes. J. Peptide Res. 49(5), 375-383 (1997). • Useful information for those researchers contemplating the use of photoaffinity techniques.
6. Dormán G, Prestwich GD. Benzophenone photophores in biochemistry. Biochem. 33(19), 5661-5673 (1994).
7. Luger K, Mader AW, Richmond RK et al. Crystal structure of the nucleosome core particle at 2.8 Å resolution. Nature 389, 251-260 (1997).
8. van Aalten DM, DiRusso CC, Knudsen J. The structural basis of acyl coenzyme A-dependent regulation of the transcription factor FadR. EMBO J. 20, 2041-2050 (2001).
9. Steen H, Jensen ON. Analysis of protein-nucleic acid interactions by photochemical cross-linking and mass spectrometry. Mass Spect. Rev. 21, 163-182 (2002).
10. Sastry S, Ross BM. RNA-binding site in T7 RNA polymerase. Proc. Natl Acad. Sci. USA 95, 9111-9116 (1998).
11. Meisenheimer K, Koch T. Photocross-linking of nucleic acids to associated proteins. Crit. Rev. Biochem. Mol. Biol. 32, 101-140 (1997).
12. Golden MC, Resing KA, Collins BD et al. Mass spectral characterization of a protein-nucleic acid photocrosslink. Protein Sci. 8, 2806-2812 (1999).
13. Steen H, Petersen J, Mann M et al. Mass spectrometric analysis of a UV-cross-linked protein-DNA complex: tryptophans 54 and 88 of E. coli SSB cross-link to DNA. Protein Sci. 10, 1989-2001 (2001).
14. Geyer H, Geyer R, Pingoud V. A novel strategy for the identification of protein-DNA contacts by photocrosslinking and mass spectrometry. Nucleic Acids Res. 32(16), e132 (2004).
15. Cusick ME, Klitgord N, Vidal M et al. Interactome: gateway into systems biology. Human Mol. Gen. 14(2), R171-R181 (2005). • Highlights the importance of methods such as photoaffinity labeling and mass spectrometry that can enhance our ability to define biomolecule interactions on the molecular level.
16. Hatanaka Y, Sadakane Y. Photoaffinity labeling in drug discovery and developments: chemical gateway for entering proteomic frontier. Curr. Topics Med. Chem. 2, 271-288 (2002).
17. Price D, Park I, Avraham H. Methods for the study of protein-protein interactions in cancer cell biology. Methods Mol. Biol. 218, 255-267 (2003).
18. Jahn O, Eckart K, Tezval H et al. Characterization of peptide-protein interactions using photoaffinity labeling and LC/MS. Anal. BioAnal. Chem. 378, 1031-1036 (2004).
19. Mills JS, Miettinen HM, Barnidge D et al. Identification of a ligand binding site in the human neutrophil formyl peptide receptor using a site-specific fluorescent photoaffinity label and mass spectrometry. J. Biol. Chem. 273(17), 10428-10435 (1998).
20. Girault S, Sagan S, Bolbach G et al. The use of photolabelled peptides to localize the substance-P-binding site in the human neurokinin-1 tachykinin receptor. Eur. J. Biochem. 240, 215-222 (1996).
21. Ploug M. Identification of specific sites involved in ligand binding by photoaffinity labeling of the receptor for the urokinase-type plasminogen activator. Residues located at equivalent positions in uPAR domains I and III participate in the assembly of a composite ligand-binding site. Biochemistry 37, 16494-16505 (1998).
22. Perrin MH, Fischer WH, Kunitake KS et al. Expression, purification, and characterization of a soluble form of the first extracellular domain of the human type 1 corticotropin realeasing factor receptor. J. Biol. Chem. 276(34), 31528-31534 (2001).
23. Jahn O, Eckart K, Brauns O et al. The binding protein of corticotrophin-releasing factor: ligand-binding site and subunit structure. Proc. Natl Acad. Sci. USA 99(19), 12055-12060 (2002).
24. Jahn O, Tezval H, Spiess J et al. Tandem mass spectrometric characterization of branched peptides derived from photoaffinity labeling. Int. J. Mass Spec. 228, 527-540 (2003).
25. Sachon E, Bolbach G, Lavielle S et al. Met174 side chain is the site of photoinsertion of a substance P competitive peptide antagonist photoreactive in position 8. FEBS Lett. 544, 45-49 (2003).
26. Sachon E, Tasseau O, Lavielle S et al. Isotope and affinity tags in photoreactive substance P analogues to identify the covalent linkage within the NK-1 receptor by MALDI-TOF analysis. Anal. Chem. 75, 6536-6543 (2003).
27. Goshe MB, Smith RD. Stable isotope-coded proteomic mass spectrometry. Curr. Opin. Biotech. 14, 101-109 (2003).
28. Jahn O, Hofmann B, Brauns O et al. The use of multiple ion chromatograms in on-line HPLC-MS for the characterization of post-translational and chemical modifications of proteins. Int. J. Mass Spec. 214, 37-51 (2002).
29. Olcott MC, Andersson J, Sjöberg B-M. Localization and characterization of two nucleotide-binding sites on the anaerobic ribonucleotide reductase from bacteriophage T4. J. Biol. Chem. 273(38), 24853-24860 (1998).
30. Kramer W, Sauber K, Baringhaus K-H et al. Identification of the bile acid-binding site of the ileal lipid-binding protein by photoaffinity labeling, matrix-assisted laser desorption ionization-mass spectrometry, and NMR structure. J. Biol. Chem. 276(10), 7291-7301 (2001).
31. + glucose cotransporter SGLT1 contains a binding site for alkyl glucosides. Biochem. 43, 10944-10951 (2004).
32. Last-Barney K, Davidson W, Cardozo M et al. Binding site elucidation of hydantoin-based antagonists of LFA-1 using multidisciplinary technologies: evidence for the allosteric inhibition of a protein-protein interaction. J. Am. Chem. Soc. 123, 5643-5650 (2001).
33. LeRiche T, Skorey K, Roy P et al. Using mass spectrometry to study the photo-affinity labeling of protein tyrosine phosphatase 1B. Int. J. Mass Spec. 238, 99-106 (2004).
34. Wu Z, Hasan A, Liu T, Teller D, Crabb J. Identification of CRALBP ligand interactions by photoaffinity labeling, hydrogen/deuterium exchange, and structural modeling. J. Biol. Chem. 279 (26), 27357-27364 (2004).
35. Wen B, Doneanu CE, Gartner CA, Roberts AG, Atkins WM, Nelson SD. Fluorescent photoaffinity labeling of cytochrome P450 3A4 by lapechenole: identification of modification sites by mass spectrometry. Biochem. 44, 1833-1845 (2005).
36. Borchers C, Boer R, Klemm K et al. Characterization of the dexniguldipine binding site in the multidrug resistance-related transport protein P-glycoprotein by photoaffinity labeling and mass spectrometry. Mol. Pharm. 61(6), 1366-1376 (2002).
37. Ecker GF, Csaszar E, Kopp S et al. Identification of ligand-binding regions of P-glycoprotein by activated-pharmacophore photoaffinity labeling and matrix-assisted laser desorption/ionization mass spectrometry. Mol. Pharm. 61(3), 637-648 (2002).
38. Pleban K, Kopp S, Csaszar E et al. P-glycoprotein substrate binding domains are located at the transmembrane domain interfaces: a combined photoaffinity labeling-protein homology modeling approach. Mol. Pharm. 67(2), 365-374 (2005).
39. Webb Y, Zhou X, Ngo L et al. Photoaffinity labeling and mass spectrometry identify ribosomal protein S3 as a potential target for hybrid polar cytodifferentiation agents. J. Biol. Chem. 274(20), 14280-14287 (1999).
40. 14C]Carboplatin-binding proteins reveals reduced expression and disorganization of actin and filamin in cisplatin-resistant cell lines. Mol. Pharm. 66(4), 789-793 (2004).
41. Davidson W, McGibbon G, White P et al. Characterization of the binding site for inhibitors of the HPV11 E1-E2 protein interaction on the E2 transactivation domain by photoaffinity labeling and mass spectrometry. Anal. Chem. 76(7), 2095-2102 (2004).
42. Bogdanov B, Smith RD. Proteomics by FTICR mass spectrometry: top down and bottom up. Mass Spec. Rev. 24, 168-200 (2005). •• Provides an informative broad overview of recent technological developments and applications of Fourier transform ion cyclotron resonance (FTICR) mass spectrometry (MS) involving proteins and peptides.
43. Martin SE, Shabanowitz J, Hunt DF, Marto JA. Subfemtomole MS and MS/MS peptide sequence analysis using nano-HPLC micro-ESI Fouier Transform Ion Cyclotron Resonance Mass Spectrometry. Anal. Chem. 72, 4266-4274 (2000). • Example of the tremendous analytical sensitivity achievable with FTICR-MS combined with nano-scale liquid chromatography for the analysis of peptides.
44. Lafitte D, Benezech V, Bompart J et al. Characterization of low affinity complexes between calmodulin and pyrazine derivatives by electrospray ionization mass spectrometry. J. Mass Spec. 32, 87-93 (1997).
45. Al-Mawsawi LQ, Fikkert, V, Dayam R et al. Discovery of a small-molecule HIV-1 integrase inhibitor-binding site. Proc. Natl Acad. Sci. USA 103(26), 10080-10085 (2006).
46. Ecker GF, Pleban K, Kopp S et al. A three-dimensional model for the substrate binding domain of the multidrug ATP binding cassette transporter LmrA. Mol. Pharm. 66(5), 1169-1179 (2004).